Dartmouth-Hitchcock Medical Center clinical trials

Listed in the registry as: University, hospital or other organization.

The registry lists 486 studies whose lead sponsor is Dartmouth-Hitchcock Medical Center. 69 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 21, 2026.

Keep track of what changes. Save the Dartmouth-Hitchcock Medical Center studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Status

Completed: 322
Terminated: 54
Recruiting: 47
Withdrawn: 27
Not yet recruiting: 18
Active, not recruiting: 13

Phase

Phase 2: 55
Phase 1: 39
Phase 4: 20
Phase 3: 14
Early Phase 1: 12

Where

United States: 459
Tanzania: 5
Canada: 4
Brazil: 1
Puerto Rico: 1
United Kingdom: 1

Focus areas

Conditions Dartmouth-Hitchcock Medical Center leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Breast Neoplasms36 Schizophrenia27 Psychotic Disorders21 Mental Disorders18 Depression17 Neoplasms17 Bipolar Disorder15 Substance-Related Disorders15 Epilepsy14 Lung Neoplasms12 Stress Disorders, Post-Traumatic11 Infections10

Studies

Recruiting first, then most recently updated. Showing 50 of 486. Browse all 486 →